Dacogen - Nucleoside Metabolic Inhibitor For Myelodysplastic Syndromes | Treats All Fab Subtypes, Affordable Quality

Clients can avail from us excellent quality Dacogen. These are nucleoside metabolic inhibitors, which are used for the treatment of myelodysplastic syndromes (MDS), denovo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia). Also, these Dacogen are used for treating intermediate-1, intermediate- 2, and high-risk International Prognostic Scoring System groups. Clients can avail from us this range of Dacogen at most affordable prices.